| Bioactivity | Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor. Pomotrelvir has antiviral activity and can be used in the research of novel coronavirus (COVID-19)[1]. |
| Name | Pomotrelvir |
| CAS | 2713437-86-4 |
| Formula | C23H26ClN5O3 |
| Molar Mass | 455.94 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jessica R. Spengler, et al. Meeting report: 35th International Conference on Antiviral Research in Seattle, Washington, USA – March 21–25, 2022. |
Pomotrelvir
CAS: 2713437-86-4 F: C23H26ClN5O3 W: 455.94
Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor. Pomotrelvir has antiviral activi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.